|
Phase I study of the anti-BTLA antibody icatolimab as a single agent or in combination with toripalimab in relapsed/refractory lymphomas. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - Shanghai Junshi BioSciences |
|
|
No Relationships to Disclose |
|
|
Employment - Shanghai Junshi BioSciences |
Stock and Other Ownership Interests - Shanghai Junshi BioSciences |
|
|
Employment - Shanghai Junshi BioSciences; TopAlliance BioSciences Inc |
Leadership - Shanghai Junshi BioSciences |
Stock and Other Ownership Interests - Shanghai Junshi BioSciences |
Patents, Royalties, Other Intellectual Property - Patent applications as employee of TopAlliance Biosciences Inc. |
|
|
Employment - Top Alliance BioScience |
|
|
No Relationships to Disclose |